Episode 20 of this series of the Mantell Associates Network welcomes Jeff Galvin, CEO and Founder of American Gene Technologies™ (AGT).
Jeff earned his BA degree in Economics from Harvard in 1981 and has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies, including one in the medical-technology arena that was sold to Varian, the leading maker of linear accelerators used in cancer therapy. Following Jeff’s startup experience, he retired to become an Angel Investor in real estate and high tech. He came out of retirement to found and fund AGT after meeting Roscoe Brady at NIH.
In this episode, Alessandro speaks with Jeff who shares his thoughts on leadership and the future of Cell & Gene Therapy, and discusses AGT’s mission and goal to cure nearly any monogenic loss of function disorder, from idea to first human efficacy.
American Gene Technologies™(AGT) is a private biotechnology company supported by accredited investors. The company develops genetic medicines that meet unmet medical needs in inherited or acquired diseases through the application of viral vector technology. AGT is pioneering disease solutions to achieve permanent cures for human diseases. You can also listen to this podcast on the following streams. The aim of the Mantell Associates Network Podcast is to connect people all around the world and empower people and businesses by sharing the stories, advice and outlook of influential leaders at market-leading companies across the industry. This podcasts provides exposure for the individuals and businesses currently doing great things, and works to unify the Pharmaceutical & Life Science industry. You can also listen to this podcast on the following streams:
Mantell Associates is a specialist Pharmaceutical and Life Sciences Recruitment organisation. To find out how we can help with your headhunting or recruitment needs, or if joining us on the podcast and sharing your experience with the rest of the Pharmaceutical & Life Science industry is something you’d be interested in doing, contact us on +44 (0)20 3854 7700.